塔科苏博综合征和性别差异:探索病理生理机制和临床差异,以实现个性化的患者管理方法
Simona Giubilato1, Giuseppina Maura Francese2, Maria Teresa Manes3
1Cardiology Department, Cannizzaro Hospital, 95126 Catania, Italy.
Journal of clinical medicine
|August 29, 2024
概括
在急性冠状动脉综合征 (ACS) 病例中,经常忽略Takotsubo综合征 (TTS) 或心碎综合征. 本综述强调了TTS的性别差异,强调了为更好的患者结果量身定制的诊断和管理策略.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 病理生理学 病理生理学
背景情况:
- 塔科苏博综合征 (TTS) 或心碎综合征是一种可逆的心脏病,经常被误认为是急性冠状动脉综合征 (ACS).
- 它的发病率不断增加和与ACS的重叠有助于频繁的不足诊断.
- 病理生理学包括冠状动脉,交感神经系统过度活跃,以及过多的catecholamine.
研究的目的:
- 为了提供一个最新的概述的性别差异在Takotsubo综合征.
- 突出承认和解决TTS病理生理学,表现和结果中性别特异性的差异的重要性.
- 强调需要针对TTS量身定制的诊断和管理策略.
主要方法:
- 从案例系列,回顾性分析,前性注册表和专家意见中审查现有数据.
- 对当前文献的分析,重点关注TTS中的性别差异.
- 综合信息,提供诊断和管理方法的最新概述.
主要成果:
- 越来越多的人认识到TTS病理生理学,临床表现和患者结果中的显著性别差异.
- 诊断TTS需要一种多模式的方法,包括临床怀疑和特定的诊断算法.
- 个性化管理至关重要,考虑到并发症,冠状动脉疾病 (CAD) 等并发症和个体患者因素.
结论:
- 塔科苏博综合征的性别差异越来越明显,需要特别注意.
- 定制的诊断和管理策略对于优化TTS患者护理至关重要.
- 需要进一步的研究,以充分阐明TTS的性别特异性方面.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
22.4K
相关概念视频
01:27Panic Disorder
52
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
52
01:29Pathophysiology of Cardiac Performance
616
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
616
01:27Psychoneuroimmunology: Cardiovascular Disease
27
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
27
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:17Increased pulse rate
651
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
651
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404